Current therapy of cutaneous melanoma.

Mays, S R; Nelson, B R

Mays, S R; Nelson, B R.

Afiliación

Mays SR; Department of Dermatology, University of Texas Medical School, Houston, USA.

Cutis ; 63(5): 293-8, 1999 May.

Article en En | MEDLINE | ID: mdl-10349545

RESUMEN

We review the current therapy for cutaneous malignant melanoma. Early surgical resection offers the best likelihood of cure. The initial staging of melanoma patients determines subsequent therapeutic decisions and follow-up care. The prognosis and appropriate therapy for each stage of melanoma are discussed. We review the controversy over lymph node dissection, and recent recommendations for the use of lymphoscintigraphy. Interferon-alpha continues to be the only Food and Drug Administration-approved adjuvant therapy for high-risk patients. In addition, the follow-up care of melanoma patients will be discussed.

Asunto(s)

Antineoplásicos/uso terapéutico; Interferón-alfa/uso terapéutico; Melanoma/tratamiento farmacológico; Melanoma/cirugía; Neoplasias Cutáneas/tratamiento farmacológico; Neoplasias Cutáneas/cirugía; Quimioterapia Adyuvante; Humanos; Melanoma/patología; Estadificación de Neoplasias; Pronóstico; Neoplasias Cutáneas/patología

Buscar en Google

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Interferón-alfa / Melanoma / Antineoplásicos Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Cutis Año: 1999 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Buscar en Google

Añadir a Mi BVS

Imprimir

XML

PubMed Links